Breast cancer survival, survival disparities, and guideline-based treatment.

Deirdre A HillSarah FriendLesley LomoCharles WigginsMarc BarryEric ProssnitzMelanie Royce

Published in: Breast cancer research and treatment (2018)

Lack of guideline-recommended radiotherapy or endocrine therapy contributed to survival as strongly as other established prognostic indicators. Hispanic survival disparities in this population do not appear to be attributable to treatment differences.

Keyphrases

free survival
radiation therapy
mesenchymal stem cells
bone marrow
young adults
locally advanced
combination therapy
affordable care act
health insurance
breast cancer risk
chemotherapy induced